跳至主要内容
临床试验/NCT00687518
NCT00687518已完成不适用

Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers

Rennes University Hospital1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2008年2月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
1
主要终点
serum hepcidin levels

研究概览

简要总结

The aim of this study is to measure the variations of serum and urinary hepcidin levels following a single intravenous injection of erythropoietin in healthy volunteers. Hepcidin is a major regulator of iron homeostasis. It acts by binding on ferroportin, and limits cellular efflux of iron through enterocytes and macrophages. Anemia and hypoxia are known to modulate hepcidin synthesis. In these situations, erythropoietin synthesis is increased, so it can be postulated that erythropoietin could modulate hepcidin synthesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •healthy volunteers
  • •male aged 18 - 30
  • •normal routine laboratory values
  • •normal ECG
  • •normal iron status

排除标准

  • •C282Y mutation of the HFE gene
  • •alcohol or tobacco consumption

研究组 & 干预措施

2

Placebo Comparator

Saline serum

干预措施: Placebo (Drug)

1

Experimental

erythropoietin

干预措施: Erythropoietin (Drug)

结局指标

主要结局

serum hepcidin levels

时间窗: over 24 hours

次要结局

  • urinary hepcidin levels(over 24 hours)
  • serum iron and ferritin levels(over 24 hours)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验